摘要
目的探讨糖尿病肾病(DN)患者应用高通量血液透析的预后。方法择取该院于2018年6月—2019年6月期间收治的48例糖尿病肾病患者,根据患者入院先后顺序将其划分为低量组和高量组,每组24例,低量组接受低通量血透,高量组接受高通量血透,对比两组患者的心脑血管疾病发生情况及存活率情况。结果高量组患者的心脑血管疾病情况及存活情况优于低量组,组间数据差异有统计学意义(P<0.05)。结论针对糖尿病身肾病患者给予高通量血透,相较于低通量血透能够有效降低患者心脑血管疾病发生率,提升患者的存活率,具有重要的临床意义,值得推广和应用。
Objective To investigate the prognosis of patients with diabetic nephropathy(DN)who underwent high-flux hemodialysis.Methods 48 patients with diabetic nephropathy admitted to the hospital from June 2018 to June 2019 were divided into low-volume and high-volume groups according to the order of admission,24 patients in each group.The low-volume group received low-throughput hemodialysis,and the high-volume group received high-throughput hemodialysis.The incidence and survival rate of cardiovascular and cerebrovascular diseases were compared between the two groups.Results The cardiovascular and cerebrovascular diseases and survival in the high-volume group were better than those in the low-grade group.Between the two groups,the difference was a statistically significant(P<0.05).Conclusion High-throughput hemodialysis for patients with diabetic nephropathy can effectively reduce the incidence of cardiovascular and cerebrovascular diseases and improve the survival rate of patients compared with low-flux hemodialysis.It has important clinical significance and is worthy of promotion and application.
作者
夏志红
XIA Zhi-hong(Blood Purification Center,the Fifth People's Hospital of Foshan,Foshan,Guangdong Province,528211 China)
出处
《糖尿病新世界》
2019年第18期43-44,共2页
Diabetes New World Magazine
关键词
糖尿病肾病
高通量
血液透析
预后
Diabetic nephropathy
High flux
Hemodialysis
Prognosis
